| Literature DB >> 36092449 |
Madhumitha Narasimhan1, Rüdiger Simon2.
Abstract
CLAVATA3/EMBRYO SURROUNDING REGION-RELATED (CLE) signaling through receptor-like kinases (RLKs) regulates developmental transitions and responses to biotic and abiotic inputs by communicating the physiological state of cells and tissues. CLE peptides have varying signaling ranges, which can be defined as the distance between the source, i.e., the cells or tissue that secrete the peptide, and their destination, i.e., cells or tissue where the RLKs that bind the peptide and/or respond are expressed. Case-by-case analysis substantiates that CLE signaling is predominantly autocrine or paracrine, and rarely endocrine. Furthermore, upon CLE reception, the ensuing signaling responses extend from cellular to tissue, organ and whole organism level as the downstream signal gets amplified. CLE-RLK-mediated effects on tissue proliferation and differentiation, or on subsequent primordia and organ development have been widely studied. However, studying how CLE-RLK regulates different stages of proliferation and differentiation at cellular level can offer additional insights into these processes. Notably, CLE-RLK signaling also mediates diverse non-developmental effects, which are less often observed; however, this could be due to biased experimental approaches. In general, CLEs and RLKs, owing to the sequence or structural similarity, are prone to promiscuous interactions at least under experimental conditions in which they are studied. Importantly, there are regulatory mechanisms that suppress CLE-RLK cross-talk in vivo, thereby eliminating the pressure for co-evolving binding specificity. Alternatively, promiscuity in signaling may also offer evolutionary advantages and enable different CLEs to work in combination to activate or switch off different RLK signaling pathways.Entities:
Keywords: CLE; RLK; co-evolution; differentiation; non-developmental effects; proliferation; promiscuity; spatial range
Year: 2022 PMID: 36092449 PMCID: PMC9459042 DOI: 10.3389/fpls.2022.906087
Source DB: PubMed Journal: Front Plant Sci ISSN: 1664-462X Impact factor: 6.627
Summary of CLE-RLK signaling.
| CLE peptide | RLK and/or other receptors involved | Origin of the peptide | Destination of the peptide/location of RLK | Short-term (molecular, cellular) and long-term (tissue, organ, organism) effects |
|---|---|---|---|---|
| Signaling range | ||||
|
| ||||
|
| Signals through MpCLV1 | The apical notch but outside the central region that hosts central subapical cells | The meristem with the apical and subapical cells where | Short-term: Inhibits differentiation of the subapical cells |
|
| ||||
|
| Signals through MpTDR | The ventral part around the apical cell | Dorsal part where | Short-term: Inhibits proliferation of the apical meristem |
|
| ||||
|
| ||||
|
| (PpCLE1 to -7) Signal through PpRPK2 and PpCLV1a and -b | Different regions in the gametophores | Gametophore | Short-term: Initiation of formative division, maintenance of CD orientation and specification of cell fate |
|
| Protonemal filament | Likely gametophore | ||
|
| Not characterized | Likely gametophore | ||
|
| ||||
|
| Signals through (and likely binds) BAM1 | PZ of IFM and SAM | PZ where | Short-term: 1. Induces |
|
| ||||
|
| Binds and signals through CLV1; signals through RPK2, CLV2/CRN | CZ of IFM and SAM | OC where it binds and signals through CLV1 | Short-term: 1. Represses |
|
| ||||
|
| ||||
|
| Binds BAM3; signals through CLV2/CRN, RPK2 | PSE and SPC | 1. PSE and SPC where it binds and signals through BAM3 | Short-term: 1. Inhibits periclinal, formative division of SPC into proto- and metaphloem cells 2. Inhibits the acquisition of morphological changes during PSE differentiation |
|
| ||||
| 2. Likely CC and PPP where | Short-term: Inhibits CC and PPP differentiation into PSE | |||
|
| ||||
|
| Signals through CIK and CLV2 | In root: SPCs and its lineage; In stem: sieve elements | Not characterized | Short-term: Regulates periclinal, formative division of SPC into proto- and metaphloem cells |
|
| ||||
|
| Signals through PXY | Phloem | Cambium where | Short-term: 1. Triggers proliferation of procambium/cambium by upregulating |
|
| ||||
|
| Likely signals through PttPXY | Phloem | Likely vascular cambium where | Short-term: Likely induces proliferation of cambial cells, which then differentiate into xylem cells |
|
| ||||
|
| Likely signals through PtrCLV2 | Xylem | Vascular cambium | Short-term: Likely suppresses cambial cell proliferation leading to a decreased rate of xylem differentiation |
|
| ||||
|
| Binds BAM1; signals through BAM2 and -3 | Xylem precursors, particularly of protoxylem cell file positions | Likely xylem precursors of protoxylem cell file positions, where it binds and signals through BAM1, although BAM1 is broadly expressed in vascular and pericycle cells | Short-term: Prevents peri- and anticlinal divisions of xylem precursors that increases xylem and procambial cell number |
|
| ||||
|
| ||||
|
| Binds HSL1-SERK1, the RLK-coreceptor complex | MMC, meristemoids and GCs | MMC and meristemoids, where it binds and signals through HSL1 | Short-term: 1. Destabilizes SPCH to prevent MMC from acquiring its identity 2. Prevents its further asymmetric divisions |
|
| ||||
|
| ||||
|
| Signals through MtSUNN, MtCRN | Nodule primordium in root | Likely shoot where | Short-term: MtCLE13 suppresses the proliferative divisions likely right after the initial cell divisions of the cortex and pericycle |
|
| ||||
|
| Binds LjHAR1; signals through LjKLV and LjCLV2 | Nodule primordium in root | Shoot, likely in leaf phloem, where | Short-term: LjCLE-RS1 and −2 peptides negatively regulate continuous cortical cell divisions after a few rounds of initial divisions |
|
| ||||
|
| ||||
|
| Signals through TDR, CLV1, RPK2, CLV2/CRN | Nematode esophageal gland | Likely procambial cells in the root and/or the syncytial cells expressing TDR | Short-term: Induces procambial proliferative divisions |
|
| ||||
|
| Can bind and possibly signals through BAM1 and -2 | Phloem pole of the stele in basal meristem | Not characterized | Short-term: Affects the PIN1 protein level in the root |
|
| Signals through CLV1 | Pericycle cells in PR and LR | Likely companion cells where | Short-term: Not characterized |
|
| ||||
|
| Not characterized | Bases of young rosette leaves, of cauline leaves and of cotyledons of mature embryo; at both the adaxial and abaxial domains of vegetative shoot apex in developing rosette leaves | Not characterized | Short-term: Not characterized |
|
| Not characterized | Bases of young rosette leaves and floral organs; only at the adaxial domain of vegetative shoot apex in developing rosette leaves | Not characterized | Short-term: Not characterized |
|
| CLV2/CRN | Not characterized | Not characterized | Short-term: 1. Upregulates auxin synthesis genes in the IFM cells 2. Maintains PIN1 protein levels in the IFM cells |
|
| Signal through BAM1, -2, and -3 | Not characterized | Not characterized | Short-term: Not characterized |
|
| ||||
|
| Signals through BAM1 and -3 | Vascular procambium of, possibly, the root | Leaf where | Short-term: 1. Promotes ABA synthesis 2. Enables stomatal closure |
|
| ||||
|
| Not characterized | Stomatal GCs | Likely the stomatal GCs | Short-term: 1. Activates |
|
| ||||
|
| Signals through MtSUNN | Vascular tissue with increased expression near colonization sites | Not characterized | (MtCLE53/-33) Short-term: 1. Upregulates |
|
| Signals through MtSUNN | Vascular tissue with strong expression in pericycle and xylem parenchyma (no change due to colonization) | Not characterized | |
|
| Not characterized | Fungi colonizing the root | Likely the epidermal and cortical cells | Short-term: Not characterized |
|
| Binds SKM1 and signals through SKM1 and -2 | Stigma of the pistil at 22°C and expanded to the transmitting tract where pollen elongates at 30°C | Pollen where it binds SKM1 | Short-term: Retains mitochondrial dehydrogenase activity at high temperature, thus prolonging pollen viability 2. Sustains pollen performance and increases the chances of pollen tubes reaching the ovules |
|
| ||||
The list of CLE peptides and RLKs and other receptors they bind and/or signal through, their signaling range, the origin of the peptide and its destination where it exerts its effect, the short- and long-term effects covering the molecular, cellular, tissue, organ, and organism levels. ABA, abscisic acid; AM, arbuscular mycorrhiza; BAM, BARELY ANY MERISTEM; CC, companion cells; CD, cell division; CIK, CLAVATA3 INSENSITIVE RECEPTOR KINASES; CLE, CLAVATA3/EMBRYO SURROUNDING REGION-RELATED; CRN, CORYNE; CLV, CLAVATA; CZ, central zone; GC, guard cell; HSL, HAESA-LIKE 1; IFM, inflorescence meristem; LR, lateral root; MMC, meristemoid mother cell; MPK, MITOGEN-ACTIVATED PROTEIN KINASE; OC, organizing center; PC, pavement cell; PIN, PIN-FORMED; PPP, phloem pole pericycle; PRM, proximal root meristem; PSE, protophloem sieve element; PXY, PHLOEM INTERCALATED WITH XYLEM; PZ, peripheral zone; RLK, receptor-like kinase; RPK2, RECEPTOR-LIKE PROTEIN KINASE 2; SAM, shoot apical meristem; SKM, STERILITY-REGULATING KINASE MEMBER; SPC, sieve element precursor cell; SPCH, SPEECHLESS; SERK, SOMATIC EMBRYOGENESIS RECEPTOR KINASE; SUNN, SUPER NUMERIC NODULES; TDR, TDIF RECEPTOR; WOX, WUSCHEL-related HOMEOBOX 4; WUS, WUSCHEL. The name of the CLE peptide, its signaling range and the long term effects it mediates are described in bold letters.
Figure 1Schematic representation of some key aspects of different stages of asymmetric stem cell division and differentiation (A), and symmetric cell division during proliferation (B). (A) In stage 0, the CLE peptides that originate from the same or the surrounding cells send the signal to differentiate. Following the signal, the stem cell undergoes differentiation, and this process can be divided into four basic stages. First, the cell to undergo asymmetric formative division is selected (marked by a box)—stage 1. Based on the positional cues offered by neighboring cells through secreted CLE peptides (their origin and direction of diffusion are indicated by red arrow), the cell polarity and the cell division orientation are established. The cell divides producing daughter cells of unequal sizes with distinct identity (represented by striped yellow and pink cells)—stage 2. When the freshly divided stem cells are endowed with plastic identity (represented by stripes), they proliferate with the same plastic identity, or a particular cell (striped yellow) switches its identity to that of the surrounding cell (pink), under certain circumstances—stage 3. The cells further differentiate and reach its destination identity (unstriped yellow) by acquiring several morphological changes over time—stage 4. Stages 3 and 4 may also be regulated by CLE peptides, but the origin and directionality of the CLE peptides regulating stages 0, 3, and 4 are not defined in this figure as these can be case specific. (B) After the decision-making CLE peptides signal to proliferate—stage 0, the stem cells undergo proliferation, and this process comprises of two basic stages. First, the cell to undergo symmetric division is selected—stage 1. Then a symmetric cell division plane is set and the cell divides to form identical daughter cells—stage 2. The stem cells proliferate by continuous repetition of the two cell division stages. CLE peptides can induce or inhibit any of these stages of differentiation and proliferation processes.
Figure 2Spatial dimension of CLE signaling. The figure illustrates the cell or tissue of origin of the CLE peptide and its destination, and the RLK it binds to at the destination, thus defining whether the signaling type is autocrine, paracrine or endocrine. (A) Signaling in IFM: CLV3, as a paracrine signal from CZ, signals through CLV1 at the OC; CLE40, likely as an autocrine signal, signals through BAM1 at the PZ. (B) Paracrine signaling in vascular development: Arabidopsis CLE41 and CLE44 move from phloem to signal in procambium. CLE41 signals through PXY but the RLK through which CLE44 signals is unknown. In Populus, PtrCLE20 from xylem signals through an unknown RLK in procambium. (C) AON signaling from nodules: MtCLE13 from the cortical and pericycle cells of the developing nodule primordium (on the right), and both MtCLE12, -13 from young, round nodule (on the left) likely act as an endocrine signal and signal through MtSUNN in the shoot. (D) Signaling in LR: CLE3 from pericycle likely acts as a paracrine signal and moves to phloem CC to signal through CLV1. (E) Signaling during AM fungal symbiosis: Rhizophagus irregularis secretes RiCLE1 likely into the epidermal and cortical layers of the Medicago root, but the RLK that receives the CLE signal is unknown. MtCLE53 and -33 are expressed in the vascular tissues, while MtCLE53 is upregulated close to the fungal infection sites. These CLEs signal through MtSUNN the localization of which is unknown. (F,H) Signaling during root protophloem development: (F) CLE25 is expressed in SPC lineage—protophloem, metaphloem, and procambium, but where and through which RLK it signals remains unknown. (H) CLE45, expressed in PSE, mediates an autocrine signaling regulation through BAM3 and likely a paracrine signaling regulation in CC through RPK2. (G) Signaling by nematode: HsCLEB, secreted by nematodes into the procambial cells, signals through TDR but it is not clear where it is expressed. (I) Autocrine signal in vascular development: CLE9, expressed in xylem precursors, signals through BAM1 expressed in vascular cells including xylem precursors. (I–K) Signaling in leaf: (I) CLE25, expressed in vascular procambium of root, acts as an endocrine signal and signals through BAM1/3 expressed in leaves for stomatal closure. (J) CLE9 expressed in MMCs and meristemoid cells binds HSL1 expressed in the same cells and likely mediates an autocrine signaling regulation during stomatal development. (K) CLE9 likely mediates an autocrine signal through uncharacterized RLK in stomatal GCs for stomatal closure. (L) Paracrine signaling in pollen. CLE45 that expands into the transmitting tract signals through SKM1 in pollen. Various shades of pink mark the cells expressing different CLEs. Cell outlines with varying shades of blue represents different RLKs. The arrows indicate the signaling type. The brown tapering arrow—endocrine signaling; red solid arrow—paracrine signaling; red dotted arrow—autocrine signaling; black arrows—unknown signaling type due to lack of data on the RLK and/or its localization. Abbreviated cells and tissues: CZ, central zone; CC, companion cell; GC, guard cell; LR, lateral root; MMC, meristemoid mother cell; PC, pavement cell; PSE, protophloem sieve element; PZ, peripheral zone.
Figure 3Illustrations of regulatory mechanisms that prevent cross-talk between CLE peptides and RLKs. (A) Regulation of CLE peptide concentration. The illustration depicts CLE peptide regulating its own synthesis through negative feedback loop, thus containing itself from excessive expression and spreading leading to cross-talk with other RLKs. (B) Regulation of the timing of CLE and/or RLK expression. The illustration depicts CLE and RLK expression controlled by external stimuli like temperature, nutrient availability, colonization by a symbiotic organism, or after certain regulatory signals produced by the same or other cells. Thus, the temporal control of expression pattern prevents cross-talk and competitive binding. (C) Regulation of the spatial expression pattern of CLEs and RLKs. This illustration depicts spatially separated expression of two similar CLEs avoiding cross-talk with the other RLK. Thus, the spatial control of expression pattern prevents cross-talk and competitive binding. (D) Regulation of CLE-RLK binding affinity through co-receptor binding. The illustration depicts co-receptors offering high binding affinity and thus high specificity to CLE-RLK interaction leading to activation of downstream signaling with no cross-talk. CLEs exhibit high affinity to the RLK that is bound with the corresponding co-receptor (co-receptor1 for CLE1; co-receptor2 for CLE2), whereas they exhibit low binding affinity to the co-receptor unbound RLK or to the RLK bound to a different co-receptor (co-receptor1 for CLE2). (E) Regulation of CLE binding affinity through post-translational modifications. The illustration depicts post-translational modification offering high binding affinity and thus high specificity to CLE-RLK interaction leading to activation of downstream signaling with no cross-talk. The CLE peptide with post-translational modification binds to the corresponding RLK (RLK1) with higher affinity compared to its unmodified counterpart and thus avoids cross-talk with the non-specific RLK2. The green arrows and gray crosses in (D,E) represent activated and non-activated downstream signaling.